Elizabeth E. Miller

1.2k total citations
51 papers, 968 citations indexed

About

Elizabeth E. Miller is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Elizabeth E. Miller has authored 51 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Cancer Research. Recurrent topics in Elizabeth E. Miller's work include Cancer, Hypoxia, and Metabolism (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Elizabeth E. Miller is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Elizabeth E. Miller collaborates with scholars based in United States, China and United Kingdom. Elizabeth E. Miller's co-authors include T. Peter Stein, Gordon P. Buzby, James L. Mullen, K. C. Tsou, Audrey E. Evans, Mélanie Cohn, Ezra Steiger, Ernest F. Rosato, Jeffrey C. Oram-Smith and Harry M. Vars and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and JNCI Journal of the National Cancer Institute.

In The Last Decade

Elizabeth E. Miller

50 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth E. Miller United States 16 362 342 200 165 139 51 968
A L Hamill United States 12 316 0.9× 427 1.2× 229 1.1× 40 0.2× 43 0.3× 14 1.3k
Weening Rs Netherlands 15 299 0.8× 590 1.7× 82 0.4× 32 0.2× 60 0.4× 32 1.6k
Mohamed Hachicha Canada 12 183 0.5× 323 0.9× 249 1.2× 75 0.5× 135 1.0× 15 1.1k
Satoshi Funakoshi Japan 22 116 0.3× 739 2.2× 76 0.4× 75 0.5× 206 1.5× 72 1.6k
S. Barker United States 12 132 0.4× 557 1.6× 186 0.9× 34 0.2× 121 0.9× 18 1.3k
Philip Marder United States 17 98 0.3× 418 1.2× 61 0.3× 54 0.3× 237 1.7× 45 929
ME Chovaniec United States 11 189 0.5× 428 1.3× 106 0.5× 22 0.1× 65 0.5× 18 851
G. Halperin Israel 22 95 0.3× 644 1.9× 180 0.9× 227 1.4× 126 0.9× 71 1.4k
Deborah A. Rathjen Australia 17 76 0.2× 352 1.0× 106 0.5× 72 0.4× 73 0.5× 40 900
S. Basu India 18 115 0.3× 651 1.9× 58 0.3× 280 1.7× 119 0.9× 35 1.4k

Countries citing papers authored by Elizabeth E. Miller

Since Specialization
Citations

This map shows the geographic impact of Elizabeth E. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth E. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth E. Miller more than expected).

Fields of papers citing papers by Elizabeth E. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth E. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth E. Miller. The network helps show where Elizabeth E. Miller may publish in the future.

Co-authorship network of co-authors of Elizabeth E. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth E. Miller. A scholar is included among the top collaborators of Elizabeth E. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth E. Miller. Elizabeth E. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seibert, Florence B., et al.. (2019). The Significance of Antibodies to Tuberculoprotein and Polysaccharide in Resistance to Tuberculosis1,2.
2.
Ramani, Pramila, et al.. (2015). High Phosphohistone H3 Expression Correlates with Adverse Clinical, Biological, and Pathological Factors in Neuroblastomas. Journal of Histochemistry & Cytochemistry. 63(6). 397–407. 8 indexed citations
3.
Linehan, M., Elizabeth E. Miller, Patrick Anglard, Maria Merino, & Berton Zbar. (1989). Improved Detection of Allele Loss in Renal Cell Carcinomas After Removal of Leukocytes by Immunologic Selection. JNCI Journal of the National Cancer Institute. 81(4). 287–290. 12 indexed citations
4.
Torosian, Michael H., et al.. (1988). Reduction of methotrexate toxicity with improved nutritional status in tumor-bearing animals. Cancer. 61(9). 1731–1735. 12 indexed citations
5.
Torosian, Michael H. & Elizabeth E. Miller. (1988). Effect of TPN on bone marrow kinetics—therapeutic implications. Journal of Surgical Research. 45(4). 376–381. 2 indexed citations
6.
Miller, Elizabeth E.. (1986). Customer service manual. Cardinal Scholar (Ball State University). 2 indexed citations
7.
Torosian, Michael H., et al.. (1985). Enhanced tumor response to cycle-specific chemotherapy by pulse total parenteral nutrition. Journal of Surgical Research. 39(2). 103–113. 15 indexed citations
8.
Hou, De‐Yan, Hans Hoch, Gerald S. Johnston, et al.. (1985). A new 111in‐bleomycin complex for combined radiotherapy and chemotherapy. Journal of Surgical Oncology. 29(2). 91–98. 14 indexed citations
9.
Shearer, Jeffry D., Gordon P. Buzby, James L. Mullen, Elizabeth E. Miller, & Michael D. Caldwell. (1984). Alteration in pyruvate metabolism in the liver of tumor-bearing rats.. PubMed. 44(10). 4443–6. 10 indexed citations
10.
Hou, De‐Yan, et al.. (1983). Stability of 111In-Bleomycin in vivo ?Properties compared with 57Co-bleomycin. European Journal of Nuclear Medicine and Molecular Imaging. 8(12). 535–40. 15 indexed citations
11.
Torosian, Michael H., et al.. (1983). Enhanced Tumor Response to Cycle‐Specific Chemotherapy by Parenteral Amino Acid Administration. Journal of Parenteral and Enteral Nutrition. 7(4). 337–345. 24 indexed citations
12.
Lanza‐Jacoby, Susan, Elizabeth E. Miller, & Francis E. Rosato. (1982). Changes in the activities of lipoprotein lipase and the lipogenic enzymes in tumor‐bearing rats. Lipids. 17(12). 944–949. 18 indexed citations
13.
Miller, Elizabeth E., et al.. (1980). Acridine phosphate as a substrate for enzyme-activated DNA stain.. Journal of Histochemistry & Cytochemistry. 28(9). 1032–1036. 2 indexed citations
14.
Miller, Elizabeth E.. (1980). Immunity and drug resistance in a mouse glioma. Journal of Surgical Oncology. 14(2). 125–132. 2 indexed citations
15.
Miller, Elizabeth E., et al.. (1978). Preliminary report of the distribution of [14C]penicillic acid in rats: autoradiographic technique.. PubMed. 39(11). 1863–5. 1 indexed citations
16.
Miller, Elizabeth E., et al.. (1977). The effect of surgical removal of a rat sarcoma on lymphocyte cytotoxicity. Journal of Surgical Oncology. 9(3). 307–311. 3 indexed citations
17.
Miller, Elizabeth E., et al.. (1976). 5′‐Nucleotide Phosphodiesterase Activity of Floxuridine‐Resistant Mouse Glioma. Journal of Pharmaceutical Sciences. 65(3). 384–387. 4 indexed citations
18.
Miller, Elizabeth E., et al.. (1976). Cytotoxicity reactions during immunotherapy of melanoma with neuraminidase altered autologous tumor cells. Journal of Surgical Oncology. 8(1). 31–34. 2 indexed citations
19.
Tsou, K. C., et al.. (1970). Synthesis of 5-iodo-3-indolylphosphodiesters of 5-fluorodeoxyuridine as possible chromogenic cancer chemotherapeutic agents. Journal of Medicinal Chemistry. 13(4). 765–768. 8 indexed citations
20.
Miller, Elizabeth E. & P. Bernfeld. (1959). Influence of the supporting medium on the fractionation of proteins by zone electrophoresis. Journal of Chromatography A. 2. 519–524. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A L Hamill Breakdown of academic impact, for papers by Weening Rs Breakdown of academic impact, for papers by Mohamed Hachicha Breakdown of academic impact, for papers by Satoshi Funakoshi Breakdown of academic impact, for papers by S. Barker Breakdown of academic impact, for papers by Philip Marder Breakdown of academic impact, for papers by ME Chovaniec Breakdown of academic impact, for papers by G. Halperin Breakdown of academic impact, for papers by Deborah A. Rathjen Breakdown of academic impact, for papers by S. Basu
Rankless by CCL
2026